Latest Posts

Posted on March 21, 2012 by |
An IdeaScale page was launched by US Federal officials this week to collect ideas for reducing technological barriers encountered by disabled individuals when interacting with the federal government as employees or citizens seeking services or information. This information gathering exercise…
Read more »

Posted on March 21, 2012 by |
Does noncompliance by clinical trial participants put future patients at risk? The Consumer Health Information Corporation says there might be a link between participant nonadherence and postmarketing safety issues. According to an article recently published in the Drug Information Association’s Drug Information Journal,…
Read more »

Posted on March 21, 2012 by |
In a memorandum issued on Tuesday, March 20, 2012, OMB directed Federal agencies to consider the cumulative effects of new regulatory requirments and take active steps to avoid them. Sunstein calls on agencies to follow several steps to identify cumulative…
Read more »

Posted on March 20, 2012 by |
FDA recently issued a new procedural guidance on IRB continuing review of previously approved research. Finalized in February 2012, this guidance supersedes the 1998 Information Sheet guidance on continuing review and reflects an ongoing effort to harmonize FDA’s regulatory requirements…
Read more »

Posted on March 14, 2012 by |
A recent report published by the Friends of the Earth (FOE) calls for a “moratorium on the release and commercial use of synthetic organisms and products”.  See the press release here.  A report has also been generated, entitled “The Principles for…
Read more »

Posted on March 13, 2012 by |
I hope everyone is getting ready for this years’ UGM. We have a number of great things in the works and I am excited to be able to show everyone not only what we have done but also our plans…
Read more »